LEPTOMENINGEAL METASTASES
Clinical trials for LEPTOMENINGEAL METASTASES explained in plain language.
Never miss a new study
Get alerted when new LEPTOMENINGEAL METASTASES trials appear
Sign up with your email to follow new studies for LEPTOMENINGEAL METASTASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted radiation battle: full coverage vs. symptom spot treatment for advanced cancer
Disease control CompletedThis study tested which of two radiation approaches works better to control cancer that has spread to the fluid-filled spaces around the brain and spine. One method treats the entire fluid system with proton radiation, while the other targets only symptomatic areas with photon ra…
Matched conditions: LEPTOMENINGEAL METASTASES
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
First trial tests immune drug and radiation for devastating brain spread
Disease control CompletedThis early-stage study aimed to find a safe dose of a two-part treatment for patients with leptomeningeal disease, a serious condition where cancer spreads to the fluid around the brain and spine. Sixteen patients received the immunotherapy drug avelumab along with whole brain ra…
Matched conditions: LEPTOMENINGEAL METASTASES
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC